METRO
Measuring community prevalence among HIV exposed children in rural Southern Mozambique
- Durada
- 01/09/2017 - 31/08/2019
- Coordinador
- Denise Naniche
- Finançadors
- PEPFAR, Centers for Disease Control and Prevention
Mozambique’s national prevention of mother to child transmission of HIV (PMTCT) program was established in 2002 and rapidly expanded. In June 2013, the Ministry of Health launched WHO Option B+, which offers antiretroviral treatment for life to all HIV positive pregnant women. By the end of 2014, 742 health units were offering B+ out of 1272 health facilities offering PMTCT services.
In light of these efforts, Mozambique has achieved a rapid reduction in new child HIV infections, from 27,000 in 2009 to 12,000 in 2013. UNAIDS estimates that the country’s MTCT rate has decreased from 26% in 2009 to 12% in 2013. However, reliable measures of final MTCT rates after breastfeeding cessation are not available. Obtaining this information is challenging due to low retention in the PMTCT cascade. Also, though prolonged breastfeeding is common in Mozambique, we have no reliable information on duration of breastfeeding among HIV-exposed infants and children.
In order to begin assessing the impact of PMTCT efforts to date and obtain baseline information for further improvement of PMTCT programs, a programmatic evaluation to measure community HIV prevalence among HIV-exposed children after cessation of breastfeeding is urgently needed in Mozambique.
Objectives
The main objective of the METRO study is to estimate the prevalence of HIV in exposed children under 4 years of age in the community, after cessation of breastfeeding, in Southern rural Mozambique in the period between 2012 and 2016.
More specifically, the project aims:
- To describe characteristics linked with child HIV exposure and HIV vertical transmission
- To estimate the duration of breastfeeding in the population of Manhiça district and to describe demographic, health, economic, and socio-cultural, characteristics of breastfeeding women
- To estimate mortality among HIV-positive mothers and HIV-exposed children
The project takes place within a demographic surveillance platform in Manhiça and offers testing and counseling to women and their children, identifying children exposed to HIV 48 months or younger.
Impact
The results obtained from this study will provide baseline data at subnational level that can later be used to estimate trends; and also used to initiate the elimination of mother-to-child transmission (EMTCT) pre-validation process according to WHO criteria. Furthermore it will be used to inform planning of national PMTCT program activities including potential community outreach programs, among other applications.
Total funding
300,000 USD
Our Team
Principal Investigator
-
Denise Suzanne Naniche
ISGlobal team
-
Laura De La Fuente Investigadora postdoctoral
-
Elisa Blanca López Varela
-
SHEILA FERNANDEZ Investigadora postdoctoral
-
Carole Amroune Project Manager
Altres projectes
Veure projectes passatsCOMBACTE
Combatent la Resistència Bacteriana a Europa
GAMA
Development of Novel Gastrointestinal Biomarkers for Use in HIV Incidence Determination in a Sub-Saharan African Setting
Desenvolupament d'estratègies per a l'Eradicació de la Malaltia de Pian
Eradicació del Pian
Novel Marine Biomolecules against Biofilm (NoMorFilm)
Application to medical devices
COMBACTE-CARE
Combatting Bacterial Resistance in Europe - Carbapenem Resistance
MAMAH
Improving Maternal and Infant Health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women
INTE-AFRICA
Integrating and decentralizing diabetes and hypertension services in Africa
ICARIA
Improving Care through Azithromycin Research for Infants in Africa
PreFIT
Predicting the Future: Incipient Tuberculosis
Predicting the Future: Incipient Tuberculosis
Encuesta serológica Cendea de Cizur
Cendea de Cizur
Projecte de Recerca en Resposta Immunitària i Epidemiologia de Malalties Infeccioses
Conèixer la propagació. Entendre la protecció
ANTICOV
Large Clinical Trial in Africa on the Treatment of Mild Cases of COVID-19
Stool4TB
Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV
TB-RECONNECT
Reconnecting Transmission to Global Tuberculosis Control by Mapping Pathogen Transmission Events to Host Infection Status
SToolNIH
Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment Monitoring
ALIA - Las ciudades y la salud
Planificación urbana, medio ambiente y salud | Clima y salud | Resistencias Antimicrobianas
END-VOC
ENDing COVID-19 Variants Of concern through Cohort studies (END-VOC)
TwinAir
Digital Twins Enabled Indoor Air Quality Management for Healthy Living
Estudio de la propagación de bacterias y genes de resistencia a los antibióticos en el ciclo integral del agua, en el área metropolitana de Barcelona
Propagación de la resistencia en aguas
Nuevos complejos de oro (III) frente a bacterias multirresistentes
Project Code: DTS21/00004
Desarrollo de dos nuevas estrategias terapéuticas (inhibidores de bombas de expulsion y ARN antisentido) activos frente a bacterias mutliresistentes
Más allá de la supresión vírica del VIH: un cuarto noventa para mejorar la salud de personas viviendo con el VIH en España
Project Code: PI20/01654
ENDÈMIC
Community knowledge generation through scientific culture, urban ecology and art
EpiGen
Building Scalable Pathogen Genomic Epidemiology in Ethiopia
Hepatitis C Free Baleares
Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care.
FLAVOBAC
Nuevas moléculas de oro coordinadas con flavonoides contra bacterias patógenas multirresistentes prioritarias
Evaluación de la eficacia del ácido acetilsalicílico a dosis bajas en la prevención de los efectos maternos y perinatales adversos en mujeres embarazadas infectadas por el SARS-CoV-2
CaDMIA-plus
Validación continuada de la autopsia mínimamente invasiva (MIA) para la investigación de la causa de muerte en niños pequeños, y desarrollo de un centro de investigación y formación sobre el estudio de la causa de muerte
MIBio
Identification of Prematurity and Pre-Eclampsia as Causes of Mortality
MULTIPLY
MULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention
MA-CoV
Prevalence and impact of SARS-CoV-2 infection on maternal and infant health in African populations
IPERVAC-SL
Impact of perceptions of COVID-19 vaccines on health-seeking behaviours in Sierra Leone
RESPIRE
Respiratory syncytial virus (RSV) in African pregnant women and children
VITAL
Towards preparedness for new maternal vaccinations: Understanding barriers and facilitators to maternal vaccine acceptance
SARA (SARS-CoV-2 and Acetylsalicylic acid)
Efficacy of low dose acetylsalicylic acid in preventing adverse maternal and perinatal outcomes in SARS-CoV-2 infected pregnant women
HIV drug resistance (HIVDR)
Description of HIV drug resistance patterns and its association with the risk of HIV mother to child transmission among pregnant women from southern Mozambique
PROTECT
PReparing for Optimal Phase III/IV maTErnal Group B StreptococCal vaccine Trials in Africa